BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Cases. Jul 26, 2026; 14(21): 123085
Published online Jul 26, 2026. doi: 10.12998/wjcc.123085
Decoding the glycemic paradox: The imperative for frailty-centered inpatient diabetes care
Basavraj S Nagoba, Sachin S Bhavthankar, Ajay M Gavkare
Basavraj S Nagoba, Department of Microbiology, Maharashtra Institute of Medical Sciences and Research (Medical College), Latur 413531, Maharashtra, India
Sachin S Bhavthankar, Department of Biochemistry, Maharashtra Institute of Medical Sciences and Research, Latur 413512, India
Ajay M Gavkare, Department of Physiology, Government Medical College, Buldhana 443001, Maharashtra, India
Author contributions: Nagoba BS designed the overall concept and outline of the manuscript; Bhavthankar SS and Gavkare AM contributed to the discussion and design of the manuscript; Nagoba BS, Bhavthankar SS, and Gavkare AM contributed to the writing, editing the manuscript, and review of literature; all authors contributed to finalising the manuscript.
AI contribution statement: We have used Gemini as an AI tool for grammatical and typographical corrections only.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Basavraj S Nagoba, Professor, Department of Microbiology, Maharashtra Institute of Medical Sciences and Research (Medical College), Vishwanathpuram, Ambajogai Road, Latur 413531, Maharashtra, India. basavraj.nagoba@mimsr.edu.in
Received: May 8, 2026
Revised: June 8, 2026
Accepted: July 1, 2026
Published online: July 26, 2026
Processing time: 75 Days and 2 Hours
Core Tip

Core Tip: In frail older adults with type 2 diabetes, lower glycated haemoglobin levels may paradoxically be associated with increased mortality, reflecting overtreatment, hypoglycemia, and underlying physiological decline. Frailty is a key modifier of risk and should guide glycemic targets, particularly in the inpatient setting. Routine frailty assessment, individualized treatment goals, and deprescribing of high-risk therapies are essential. A shift from rigid glycemic control to a safety-focused, patient-centered approach is crucial to improve outcomes in this vulnerable population.

Write to the Help Desk